0001396677-15-000026.txt : 20150505
0001396677-15-000026.hdr.sgml : 20150505
20150505122154
ACCESSION NUMBER: 0001396677-15-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150501
FILED AS OF DATE: 20150505
DATE AS OF CHANGE: 20150505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0001050007
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 870515089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
BUSINESS PHONE: 4356556000
MAIL ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOPER STANLEY E
CENTRAL INDEX KEY: 0001265855
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23731
FILM NUMBER: 15831472
MAIL ADDRESS:
STREET 1: C/O NUTRACEUTICAL INTERNATIONAL CORP
STREET 2: 1400 KEARNS BLVD 2ND FL.
CITY: PARK CITY
STATE: UT
ZIP: 84060
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-05-01
0
0001050007
NUTRACEUTICAL INTERNATIONAL CORP
NUTR
0001265855
SOPER STANLEY E
C/O NUTRACEUTICAL INTERNATIONAL CORP
1400 KEARNS BLVD 2ND FL.
PARK CITY
UT
84060
0
1
0
0
VP, Legal Affairs
Common Stock
2015-05-01
4
M
0
5000
14.22
A
5000
D
Common Stock
2015-05-01
4
S
0
5000
19.3399
D
0
D
Employee Stock Option (right to buy)
14.22
2015-05-01
4
M
0
5000
0
D
2005-09-30
2015-09-30
Common Stock
5000
3827
D
Exercise of options expiring on September 30, 2015.
The sale reported in this Form 4 effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 9, 2015.
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $19.18 to $19.51. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The option immediately vested at the time of grant.
/s/ Alison Pitt, attorney in fact
2015-05-05